Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Xylocaine 2%
Active Ingredient: Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20mg lignocaine hydrochloride anhydrous
Dosage Forms: Multidose vial Solution for injection
Polyamp Solution for injection
Pre-filled syringe Solution for injection
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca Pty Limited, North Ryde, Australia
AstraZeneca AB, Sodertalje, Sweden
Dated this 8th day of July 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).